Kodiak Sciences (KOD) Is Up 66.3% After Strong Zenkuda GLOW2 Phase 3 Data - Has The Bull Case Changed? [Yahoo! Finance]
Kodiak Sciences Inc (KOD)
Last kodiak sciences inc earnings: 11/12 05:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
sham in treating a broad range of diabetic retinopathy patients with extended-interval intravitreal dosing and a favorable safety profile. An interesting aspect of GLOW2 is that Zenkuda's efficacy appeared consistent regardless of patients' use of GLP-1 receptor agonists, underscoring its potential relevance in a real-world diabetic population. We'll now explore how the BLA-ready profile and six-month dosing regimen for Zenkuda could influence Kodiak Sciences' broader investment narrative. Find 61 companies with promising cash flow potential yet trading below their fair value What Is Kodiak Sciences' Investment Narrative? To own Kodiak Sciences today, you have to believe Zenkuda can move from promising Phase 3 data to an approved, commercially relevant product before the balance sheet pressure bites too hard. The GLOW2 readout is clearly a swing factor here: it strengthens the case for a BLA submission and helps explain the very large share price move, but it does not elimin
Show less
Read more
Impact Snapshot
Event Time:
KOD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KOD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KOD alerts
High impacting Kodiak Sciences Inc news events
Weekly update
A roundup of the hottest topics
KOD
News
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [TheStreet.com]TheStreet.com
- Kodiak Sciences GAAP EPS of -$1.04 in-line [Seeking Alpha]Seeking Alpha
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial ResultsPR Newswire
- Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines [Seeking Alpha]Seeking Alpha
KOD
Earnings
- 3/31/26 - Miss
KOD
Sec Filings
- 3/31/26 - Form S-8
- 3/31/26 - Form 10-K
- 3/31/26 - Form 8-K
- KOD's page on the SEC website